Grey Wolf Health Corp.

TSXV:WOLF Stock Report

Market Cap: CA$60.4m

Grey Wolf Health Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Grey Wolf Health.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Consumer Retailing earnings growth4.3%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Analysis Article Jan 31

Grey Wolf Animal Health Corp.'s (CVE:WOLF) Share Price Not Quite Adding Up

Grey Wolf Animal Health Corp.'s ( CVE:WOLF ) price-to-earnings (or "P/E") ratio of 62.1x might make it look like a...
Analysis Article Oct 24

Grey Wolf Animal Health (CVE:WOLF) Has A Pretty Healthy Balance Sheet

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysis Article Aug 30

Grey Wolf Animal Health Corp.'s (CVE:WOLF) 25% Share Price Surge Not Quite Adding Up

Despite an already strong run, Grey Wolf Animal Health Corp. ( CVE:WOLF ) shares have been powering on, with a gain of...
Analysis Article Jul 17

If EPS Growth Is Important To You, Grey Wolf Animal Health (CVE:WOLF) Presents An Opportunity

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Analysis Article Jun 14

Grey Wolf Animal Health Corp.'s (CVE:WOLF) Price Is Out Of Tune With Earnings

Grey Wolf Animal Health Corp.'s ( CVE:WOLF ) price-to-earnings (or "P/E") ratio of 62.1x might make it look like a...
Analysis Article Dec 04

Investors Still Aren't Entirely Convinced By Grey Wolf Animal Health Corp.'s (CVE:WOLF) Revenues Despite 26% Price Jump

Grey Wolf Animal Health Corp. ( CVE:WOLF ) shareholders have had their patience rewarded with a 26% share price jump in...
Analysis Article Aug 23

These 4 Measures Indicate That Grey Wolf Animal Health (CVE:WOLF) Is Using Debt Reasonably Well

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Analysis Article Apr 19

It's Down 25% But Grey Wolf Animal Health Corp. (CVE:WOLF) Could Be Riskier Than It Looks

Grey Wolf Animal Health Corp. ( CVE:WOLF ) shareholders won't be pleased to see that the share price has had a very...
Analysis Article Jan 22

Grey Wolf Animal Health Corp.'s (CVE:WOLF) Shares Not Telling The Full Story

You may think that with a price-to-sales (or "P/S") ratio of 1x Grey Wolf Animal Health Corp. ( CVE:WOLF ) is a stock...

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Grey Wolf Health has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

TSXV:WOLF - Analysts future estimates and past financials data (CAD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/202637244N/A
12/31/202536234N/A
9/30/202533134N/A
6/30/202531123N/A
3/31/202529145N/A
12/31/202427112N/A
9/30/202426101N/A
6/30/202426112N/A
3/31/202425011N/A
12/31/202325122N/A
9/30/202325722N/A
6/30/202324511N/A
3/31/2023244-1-1N/A
12/31/2022233-1-1N/A
9/30/202222-300N/A
6/30/202219-300N/A
3/31/202216-211N/A
12/31/202113-122N/A
12/31/20208-111N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if WOLF's forecast earnings growth is above the savings rate (3%).

Earnings vs Market: Insufficient data to determine if WOLF's earnings are forecast to grow faster than the Canadian market

High Growth Earnings: Insufficient data to determine if WOLF's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if WOLF's revenue is forecast to grow faster than the Canadian market.

High Growth Revenue: Insufficient data to determine if WOLF's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if WOLF's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/30 22:02
End of Day Share Price 2026/06/30 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Grey Wolf Health Corp. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.